Short‐term pulmonary function trends are predictive of mortality in interstitial lung disease associated with systemic sclerosis
NS Goh, RK Hoyles, CP Denton… - Arthritis & …, 2017 - Wiley Online Library
Objective To determine the prognostic value of pulmonary function test (PFT) trends at 1 and
2 years in interstitial lung disease (ILD) associated with systemic sclerosis (SSc). Methods …
2 years in interstitial lung disease (ILD) associated with systemic sclerosis (SSc). Methods …
Health‐related quality of life in idiopathic pulmonary fibrosis: Data from the A ustralian IPF R egistry
…, SJ Ellis, NS Goh, PM Hopkins, S Macansh… - …, 2017 - Wiley Online Library
Background and objective Studies analysing the effect of worsening pulmonary physiological
impairment in idiopathic pulmonary fibrosis ( IPF ) with respect to quality of life have been …
impairment in idiopathic pulmonary fibrosis ( IPF ) with respect to quality of life have been …
The supportive care needs of people living with pulmonary fibrosis and their caregivers: a systematic review
JYT Lee, G Tikellis, TJ Corte, NS Goh… - European …, 2020 - Eur Respiratory Soc
Background People with pulmonary fibrosis often experience a protracted time to diagnosis,
high symptom burden and limited disease information. This review aimed to identify the …
high symptom burden and limited disease information. This review aimed to identify the …
Biomarker signatures for progressive idiopathic pulmonary fibrosis
Background Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease in which
circulatory biomarkers have the potential for guiding management in clinical practice. We …
circulatory biomarkers have the potential for guiding management in clinical practice. We …
Extent of fibrosis and lung function decline in patients with systemic sclerosis and interstitial lung disease: data from the SENSCIS trial
CP Denton, NS Goh, SM Humphries, TM Maher… - …, 2023 - academic.oup.com
Objective To assess associations between the extent of fibrotic interstitial lung disease (ILD)
and forced vital capacity (FVC) at baseline and change in FVC over 52 weeks in patients …
and forced vital capacity (FVC) at baseline and change in FVC over 52 weeks in patients …
[HTML][HTML] Gastroesophageal reflux and antacid therapy in IPF: analysis from the Australia IPF Registry
…, AM Mahar, S Ellis, S Macansh, NS Goh - BMC pulmonary …, 2019 - Springer
Background and objective Gastroesophageal reflux disease (GORD) is highly prevalent in
idiopathic pulmonary fibrosis (IPF) and may play a role in its pathogenesis. Recent IPF …
idiopathic pulmonary fibrosis (IPF) and may play a role in its pathogenesis. Recent IPF …
[HTML][HTML] There is detectable variation in the lipidomic profile between stable and progressive patients with idiopathic pulmonary fibrosis (IPF)
…, B Clynick, BS How, A King, EH Walters, NS Goh… - Respiratory …, 2021 - Springer
Background Idiopathic pulmonary fibrosis (IPF) is a chronic interstitial lung disease
characterized by fibrosis and progressive loss of lung function. The pathophysiological pathways …
characterized by fibrosis and progressive loss of lung function. The pathophysiological pathways …
Blood monocyte counts as a potential prognostic marker for idiopathic pulmonary fibrosis: analysis from the Australian IPF registry
…, K Symons, EH Walters, NS Goh… - European …, 2020 - Eur Respiratory Soc
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, fibrosing lung disease that
leads to unrelenting dyspnoea and chronic cough, and ultimately respiratory failure [1]. IPF is …
leads to unrelenting dyspnoea and chronic cough, and ultimately respiratory failure [1]. IPF is …
TELO-SCOPE study: a randomised, double-blind, placebo-controlled, phase 2 trial of danazol for short telomere related pulmonary fibrosis
…, H Selvadurai, C Grainge, NS Goh… - BMJ open …, 2021 - bmjopenrespres.bmj.com
Introduction Recent discoveries have identified shortened telomeres and related mutations
in people with pulmonary fibrosis (PF). There is evidence to suggest that androgens, …
in people with pulmonary fibrosis (PF). There is evidence to suggest that androgens, …
Diagnosis and management of idiopathic pulmonary fibrosis: Thoracic Society of Australia and New Zealand and Lung Foundation Australia position statements …
…, G Keir, NS Goh, M Wilsher, S De Boer… - Medical Journal of …, 2018 - Wiley Online Library
Introduction: Idiopathic pulmonary fibrosis (IPF) is a fibrosing interstitial lung disease
associated with debilitating symptoms of dyspnoea and cough, resulting in respiratory failure, …
associated with debilitating symptoms of dyspnoea and cough, resulting in respiratory failure, …